19
Trevi Therapeutics

Trevi Therapeutics

Trevi Therapeutics, Inc. develops drugs for the treatment of uremic pruritus. Its pipeline product, T111 is an oral extended release formulation for the treatment of severe chronic itching condition.

Sandy Hook - Kentucky - United States

Pharma

startup corporate



Profile statistics